Get the Stockscreener App
0.81
0.58%
0.0047
Sutro Biopharma Inc stock is traded at $0.81, with a volume of 233.41K.
It is up +0.58% in the last 24 hours and up +19.12% over the past month.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
See More
Previous Close:
$0.8053
Open:
$0.8
24h Volume:
233.41K
Relative Volume:
0.22
Market Cap:
$68.41M
Revenue:
$153.73M
Net Income/Loss:
$-106.79M
P/E Ratio:
-0.4551
EPS:
-1.78
Net Cash Flow:
$-115.93M
1W Performance:
-8.70%
1M Performance:
+19.12%
6M Performance:
-57.81%
1Y Performance:
-78.51%
1-Day Range:
$0.7966
$0.8459
1-Week Range:
$0.7966
$0.9249
52-Week Range:
$0.5231
$5.17
Sutro Biopharma Inc Stock (STRO) Company Profile
Name
Sutro Biopharma Inc
Sector
Industry
Phone
650-392-8412
Address
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Compare STRO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STRO
Sutro Biopharma Inc
|
0.81 | 68.02M | 153.73M | -106.79M | -115.93M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-16-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Mar-17-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-14-25 | Downgrade | BofA Securities | Buy → Underperform |
| Mar-14-25 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| Mar-14-25 | Downgrade | Wedbush | Outperform → Neutral |
| May-08-24 | Initiated | BofA Securities | Buy |
| Nov-09-23 | Initiated | Deutsche Bank | Buy |
| Oct-06-23 | Initiated | Oppenheimer | Outperform |
| Mar-21-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-18-22 | Resumed | Wells Fargo | Overweight |
| Jun-18-21 | Initiated | H.C. Wainwright | Buy |
| Dec-03-20 | Initiated | Stifel | Buy |
| Sep-02-20 | Initiated | Jefferies | Buy |
| Jul-16-20 | Initiated | Wells Fargo | Overweight |
| Jan-13-20 | Initiated | SunTrust | Buy |
| Oct-07-19 | Initiated | BTIG Research | Buy |
| Jul-18-19 | Initiated | Deutsche Bank | Buy |
| Apr-29-19 | Initiated | H.C. Wainwright | Buy |
| Oct-22-18 | Initiated | JMP Securities | Mkt Outperform |
| Oct-22-18 | Initiated | Piper Jaffray | Overweight |
| Oct-22-18 | Initiated | Wedbush | Outperform |
View All
Sutro Biopharma Inc Stock (STRO) Latest News
What makes Sutro Biopharma Inc. stock price move sharplySector Rotation Outlook With Historical Summary - Newser
Pattern recognition hints at Sutro Biopharma Inc. upsideShort-Term Growth Watch with Signal Prediction - Newser
News impact scoring models applied to Sutro Biopharma Inc.Long Term Equity Screener with Safety Metrics - Newser
Institutional scanner results for Sutro Biopharma Inc.Free Stock Portfolio Allocation Guidance - Newser
Sutro Biopharma Inc. stock trend outlook and recovery pathSummary of Consistent Growth Stock Picks - Newser
Understanding Sutro Biopharma Inc.’s price movementFree Stock Portfolio Allocation Guidance - Newser
Is Sutro Biopharma Inc. forming a bottoming baseDaily Technical Forecast for Quick Gains - Newser
Using Ichimoku Cloud for Sutro Biopharma Inc. technicalsFree Daily Volume Spike Trading Signals - Newser
Real time scanner hits for Sutro Biopharma Inc. explainedAI Model Forecasting Reversal and Breakout Zones - Newser
Has Sutro Biopharma Inc. found a price floorPattern Recognition Tool for ROI Investors - Newser
Is Sutro Biopharma Inc. a candidate for recovery playLow Drawdown Stock Screener with Analysis - Newser
Is Sutro Biopharma Inc. Stock a Smart Buy in 2025 Investment Analysis InsideDaily Growth Stock Pick Reports Show Bullish Signals - metal.it
Why Sutro Biopharma Inc. stock attracts strong analyst attentionFree Entry Points For Growing Stocks - Newser
Published on: 2025-07-28 22:42:30 - metal.it
How strong is Sutro Biopharma Inc. company’s balance sheetTrack top-performing stocks in real-time - jammulinksnews.com
Is Sutro Biopharma Inc. Stock a Smart Buy in 2025 Investment Analysis Inside Free Real Profit Trade Plan Suggestions - Newser
How many analysts rate Sutro Biopharma Inc. as a “Buy”Achieve consistent profits with proven methods - jammulinksnews.com
Is Sutro Biopharma Inc. stock overvalued or undervaluedFree Stock Market Forecast Reports - jammulinksnews.com
What are the latest earnings results for Sutro Biopharma Inc.Explosive portfolio gains - jammulinksnews.com
Does Sutro Biopharma Inc. stock perform well during market downturnsAccelerated wealth expansion - jammulinksnews.com
What are the technical indicators suggesting about Sutro Biopharma Inc.High-yield investments - jammulinksnews.com
What institutional investors are buying Sutro Biopharma Inc. stockUnstoppable investment returns - jammulinksnews.com
Key External Factors That Drive Sutro Biopharma Inc. Stock Price MovementsMomentum Buy Alert - Newser
What analysts say about Sutro Biopharma Inc. stockFree Capital Allocation Plans - PrintWeekIndia
Sutro Biopharma Inc. Stock Analysis and ForecastFree Capital Growth Strategies - Autocar Professional
How Sutro Biopharma Inc. stock reacts to Fed policy changesUnrivaled growth potential - jammulinksnews.com
Sutro Biopharma Inc Stock (STRO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sutro Biopharma Inc Stock (STRO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| FITZPATRICK LINDA A | CHIEF PEOPLE & COMM. OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
37,849 |
0 |
133,282 |
| Srinivasan Venkatesh | CHIEF TECH OP OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
2,500 |
0 |
54,580 |
| Borgman Anne Elizabeth | CHIEF MEDICAL OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
69,063 |
0 |
122,161 |
| Srinivasan Venkatesh | CHIEF TECH OP OFFICER |
Apr 11 '25 |
Option Exercise |
0.00 |
21,250 |
0 |
59,683 |
| NEWELL WILLIAM J | CEO |
Mar 05 '25 |
Option Exercise |
0.00 |
18,750 |
0 |
299,239 |
| FITZPATRICK LINDA A | CHIEF PEOPLE & COMM. OFFICER |
Mar 05 '25 |
Option Exercise |
0.00 |
8,750 |
0 |
99,027 |
| ALBINI EDWARD C | CFO AND SECRETARY |
Mar 05 '25 |
Option Exercise |
0.00 |
8,750 |
0 |
135,675 |
| FITZPATRICK LINDA A | CHIEF PEOPLE & COMM. OFFICER |
Mar 04 '25 |
Option Exercise |
0.00 |
9,125 |
0 |
94,025 |
| NEWELL WILLIAM J | CEO |
Mar 04 '25 |
Option Exercise |
0.00 |
31,125 |
0 |
291,625 |
| Chung Jane | PRESIDENT AND COO |
Mar 04 '25 |
Option Exercise |
0.00 |
7,875 |
0 |
100,642 |
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):